A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: resembling (46)

Irinotecan-Temozolomide

Description
Chemotherapy Protocol Sarcoma IRINOTECAN - TEMOZOLOMIDE Regimen • Sarcoma – Irinotecan-Temozolomide Indication • Recurrent or progressive Ewings sarcoma • Performance status 0, 1, 2 Toxicity
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Irinotecan-Temozolomide.pdf

InP-PAM-(cycles 5-6) v1

Description
Chemotherapy Protocol Sarcoma DOXORUBICIN-METHOTREXATE (cycles 5-6) Inpatient Regimen There are multiple versions of this protocol in use. Please ensure
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-PAM-cycles-5-6-v1.pdf

InPEtoposideIfosfamide(5dy)Ver1

Description
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (5 day) Inpatient Regimen Regimen Sarcoma-InP-Etoposide-Ifosfamide (5 day) Indication Second line treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPEtoposideIfosfamide5dyVer1.pdf

InP Ifosfamide(2day)Ver1

Description
Chemotherapy Protocol SARCOMA IFOSFAMIDE (2 day) Inpatient Regimen Regimen Sarcoma-InP-Ifosfamide (2 day) Indication Advanced or metastatic soft tissue sarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPIfosfamide2dayVer1.pdf

InP DoxorubicinIfosfamideVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-IFOSFAMIDE In-Patient Regimen Regimen Sarcoma – InP-Doxorubicin - Ifosfamide Indication Soft tissue sarcoma WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinIfosfamideVer1.pdf

InP Doxorubicin Etoposide Ifosfamide Vincristine VIDEVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-ETOPOSIDE-IFOSFAMIDE -VINCRISTINE (VIDE) Inpatient Regimen Regimen Sarcoma-InP- Doxorubicin-Etoposide-Ifosfamide-Vincristine (VIDE) Indication Ewings Sarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinEtoposideIfosfamideVincristineVIDEVer1.pdf

InP Cyclophosphamide Doxorubicin Etoposide Vincristine VCDEVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-CYCLOPHOSPHAMIDE-ETOPOSIDE-VINCRISTINE (VCDE) Inpatient Regimen Regimen Sarcoma-InP- Cyclophosphamide-Doxorubicin-Etoposide-Vincristine (VCDE) Indication Rhabdommyosarcoma Toxicity
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPCyclophosphamideDoxorubicinEtoposideVincristineVCDEVer1.pdf

Doxorubicin-Olaratumab

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-OLARATUMAB Regimen • Sarcoma – Doxorubicin-Olaratumab Indication • In combination with doxorubicin for the first line treatment of advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Doxorubicin-Olaratumab.pdf

Z-DEX dexamethasone idarubicin ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA Z-DEX-DEXAMETHASONE-IDARUBICIN Regimen Multiple Myeloma – Z-DEX-Dexamethasone-Idarubicin Indication First or subsequent line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Z-DEX-dexamethasone-idarubicin-ver1.pdf

Lenalidomide

Description
Chemotherapy Protocol MULTIPLE MYELOMA LENALIDOMIDE Regimen • Multiple Myeloma – Lenalidomide Indication • Lenalidomide is recommended, within its licensed indication, as an option for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Lenalidomide.pdf
471 to 480 of 757
Previous … 46 47 48 49 50 … Next